Legend: Palais des congrès de Montréal = CC, Le Westin Montréal = W, Intercontinental Montréal = I
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
Activity Details
|
|
Tweet | ||
| 326 | Tue, 8/6/2013, 10:30 AM - 12:20 PM | CC-513b | |
| Critical Aspects of Dose-Finding in Drug Development — Invited Papers | |||
| Biopharmaceutical Section , Biometrics Section | |||
| Organizer(s): David I. Ohlssen, Novartis Pharmaceuticals Corporation | |||
| Chair(s): David I. Ohlssen, Novartis Pharmaceuticals Corporation | |||
| 10:35 AM | Contribution of Different Design Components to the Efficiency of Response-Adaptive Dose-Ranging Studies — Vladimir Dragalin, Aptiv Solutions | ||
| 11:00 AM | Leveraging Longitudinal Data in Dose-Finding Studies — Chyi-Hung Hsu, Janssen Research & Development ; Jose Carlos Pinheiro, Janssen R&D | ||
| 11:25 AM | Sizing a Phase IIb Trial: Using the Predictive Values from a Nonlinear Model — Jerry John Weaver, Novartis Pharmaceuticals Corporation | ||
| 11:50 AM | Discussant: Yanming Yin, FDA | ||
| 12:10 PM | Floor Discussion | ||
2013 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Copyright © American Statistical Association.